Bacchus Therapeutics
Bacchus Therapeutics is a biotech company that exploits cancer’s hypermetabolic state by targeting specific cancer metabolic pathways. We identified a novel pathway to target that is synthetic lethal to the cancer-causing gene, MYC. Our drug is translatable to all MYC-driven cancers, which encompass about 50-70% of all cancers.
Read MoreScanlily
Scanlily provides a revolutionary QR code-based method for managing assets and equipment. Its unique mobile and QR-centric design makes it completely unlike (and superior to) current SaaS asset management systems. The system is flexible and can be adapted to different types of physical items such as items in storage, office…
Read MoreRecens Respiratio
Recens Respiratio is developing technology to automate/ optimize/personalize nasal cannula therapies using machine learning and fluid modeling. The purpose of this innovation is to accelerate hospital discharge for certain patients with an acute respiratory disease. Our desired final product is an autonomous nasal cannula system that will respond in real-time…
Read MoreAllis Innovations
Allis Innovations leverages technology and best in practice expertise to improve operating room service efficiency. Our initial technology, the Instreyed Surgical Instrument Detection Platform, applies computer vision models to predict surgical instruments. This platform improves efficiency and quality of tray assembly, the most labor intensive step in Central Sterile surgical…
Read More